Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

NOVEL THIOSEMICARBAZONE IRON CHELATORS INDUCE UP-REGULATION AND PHOSPHORYLATION OF THE METASTASIS SUPPRESSOR, NDRG1: A NEW STRATEGY FOR THE TREATMENT OF PANCREATIC CANCER.

Zaklina Kovacevic, Sherin Chikhani, David B Lovejoy and Des R. Richardson
Molecular Pharmacology June 30, 2011, mol.111.073627; DOI: https://doi.org/10.1124/mol.111.073627
Zaklina Kovacevic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sherin Chikhani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David B Lovejoy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Des R. Richardson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

mol.111.073627
DOI 
https://doi.org/10.1124/mol.111.073627
PubMed 
21719465

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received May 18, 2011
  • Revision received June 13, 2011
  • Accepted June 30, 2011
  • Published online June 30, 2011.

Article Versions

  • You are currently viewing an Earlier version of this article (June 30, 2011 - 11:37).
  • earlier version (August 16, 2011 - 07:55).
  • View the most recent version of this article
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Zaklina Kovacevic,
  2. Sherin Chikhani,
  3. David B Lovejoy and
  4. Des R. Richardson*
  1. University of Sydney
  1. ↵* Corresponding author; email: d.richardson{at}med.usyd.edu.au

Statistics from Altmetric.com

Article usage

Article usage: June 2011 to January 2021

AbstractFullPdf
Jun 20112609
Jul 20111850170
Aug 2011173093
Sep 2011261856
Oct 20113142838
Nov 20111012045
Dec 2011641325
Jan 201268529
Feb 2012601132
Mar 2012721139
Apr 201252741
May 2012621632
Jun 2012351626
Jul 201226619
Aug 201241436
Sep 2012461237
Oct 2012312636
Nov 2012352234
Dec 2012361553
Jan 2013985548
Feb 2013263631
Mar 2013292732
Apr 2013473339
May 2013342525
Jun 2013222829
Jul 2013312122
Aug 2013161336
Sep 2013151836
Oct 2013351637
Nov 201372826
Dec 2013142141
Jan 2014211313
Feb 2014241021
Mar 2014283327
Apr 2014201625
May 2014233040
Jun 2014221521
Jul 2014252015
Aug 2014132415
Sep 2014101522
Oct 2014253813
Nov 2014403220
Dec 2014251517
Jan 2015191713
Feb 201582019
Mar 2015323527
Apr 2015211229
May 2015105038
Jun 2015221733
Jul 2015142025
Aug 2015233418
Sep 2015243430
Oct 2015113016
Nov 2015133316
Dec 201591415
Jan 201618715
Feb 2016174623
Mar 2016123421
Apr 20169820
May 2016162724
Jun 2016192734
Jul 2016283435
Aug 2016261629
Sep 201691216
Oct 201673011
Nov 201631915
Dec 201622513
Jan 201713516
Feb 201733436
Mar 201774628
Apr 201731774
May 201722074
Jun 201772830
Jul 201751827
Aug 201751421
Sep 201752933
Oct 201783037
Nov 2017123123
Dec 201783721
Jan 2018113325
Feb 2018102624
Mar 201862721
Apr 2018173021
May 2018162525
Jun 2018151921
Jul 2018151429
Aug 2018610216
Sep 201846722
Oct 201875425
Nov 2018109523
Dec 2018582817
Jan 20194739
Feb 20196145
Mar 201932210
Apr 20193079
May 20192708
Jun 201927217
Jul 201943413
Aug 20192355
Sep 20191790
Oct 201944212
Nov 20194159
Dec 20195139
Jan 202020111
Feb 20202946
Mar 20202737
Apr 20202515
May 20201523
Jun 20205431
Jul 20201922
Aug 20201617
Sep 20204804
Oct 20203257
Nov 202030412
Dec 20204236
Jan 20211345

Next
Back to top

In this issue

Molecular Pharmacology: 99 (2)
Molecular Pharmacology
Vol. 99, Issue 2
1 Feb 2021
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
NOVEL THIOSEMICARBAZONE IRON CHELATORS INDUCE UP-REGULATION AND PHOSPHORYLATION OF THE METASTASIS SUPPRESSOR, NDRG1: A NEW STRATEGY FOR THE TREATMENT OF PANCREATIC CANCER.
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

NOVEL THIOSEMICARBAZONE IRON CHELATORS INDUCE UP-REGULATION AND PHOSPHORYLATION OF THE METASTASIS SUPPRESSOR, NDRG1: A NEW STRATEGY FOR THE TREATMENT OF PANCREATIC CANCER.

Zaklina Kovacevic, Sherin Chikhani, David B Lovejoy and Des R. Richardson
Molecular Pharmacology June 30, 2011, mol.111.073627; DOI: https://doi.org/10.1124/mol.111.073627

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

NOVEL THIOSEMICARBAZONE IRON CHELATORS INDUCE UP-REGULATION AND PHOSPHORYLATION OF THE METASTASIS SUPPRESSOR, NDRG1: A NEW STRATEGY FOR THE TREATMENT OF PANCREATIC CANCER.

Zaklina Kovacevic, Sherin Chikhani, David B Lovejoy and Des R. Richardson
Molecular Pharmacology June 30, 2011, mol.111.073627; DOI: https://doi.org/10.1124/mol.111.073627
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • GABAAR Molecular Identity in Oligodendrocytes
  • Editing TOP2α Intron-19 5′ SS Circumvents Drug Resistance
  • SerpinA3N and drug induced liver injury
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics